<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Common forms of hereditary ataxia (HA)</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left" rowspan="2">Hereditary ataxia</th>
    <th align="left" rowspan="2">Ethnicity</th>
    <th align="left" rowspan="2">Gene and locus of mutation</th>
    <th align="left" colspan="2">Clinical presentation</th>
    <th align="left" rowspan="2">Neuroimaging finding</th>
    <th align="left" rowspan="2">Neurometabolite finding</th>
    <th align="left" rowspan="2">Biochemical finding</th>
    <th align="left" rowspan="2">Reference</th>
   </tr>
   <tr>
    <th align="left">Motor symptom</th>
    <th align="left">Non-motor symptom</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" colspan="9">Autosomal dominant</td>
   </tr>
   <tr>
    <td align="left"> SCA1</td>
    <td align="left">Russian, Polish, Indian, Japanese and Eastern Siberian</td>
    <td align="left">ATXN1 on chromosome 6p22.3</td>
    <td align="left">Gait ataxia, pyramidal, extrapyramidal and bulbar signs, dysarthria, nystagmus, chorea and peripheral neuropathy</td>
    <td align="left">Cognitive impairment and respiratory failure</td>
    <td align="left">Atrophy of the cerebellum, brainstem and cerebral frontal lobe</td>
    <td align="left">
     <p>Decreased glutamate, tNAA, NAA/Cr ratio and Cho/Cr ratio</p>
     <p>Increased glutamine, myoinositol and tCr</p>
    </td>
    <td align="left">Increased lactate</td>
    <td align="left">[
     <xref ref-type="bibr" rid="CR6">6</xref>–
     <xref ref-type="bibr" rid="CR12">12</xref>]
    </td>
   </tr>
   <tr>
    <td align="left"> SCA2</td>
    <td align="left">Cuban, Korean, South African and Indian</td>
    <td align="left">ATXN2 on chromosome 12q24.12</td>
    <td align="left">Gait ataxia, pyramidal and extrapyramidal signs, dysarthria and dysphagia</td>
    <td align="left">Cognitive impairment, psychiatric symptoms, sleep disturbances and slow saccadic eye movements</td>
    <td align="left">Atrophy of cerebellum, brainstem, cerebral frontal lobe, spinal cord and cranial nerves III to XII</td>
    <td align="left">
     <p>Decreased glutamate, tNAA, NAA/Cr ratio and Cho/Cr ratio</p>
     <p>Increased myoinositol and tCr</p>
    </td>
    <td align="left">
     <p>Decreased GSH, GST, SOD, CAT, zinc, iron, copper, erythropoietin, dopamine metabolites and ethanolamine</p>
     <p>Increased MDA</p>
    </td>
    <td align="left">[
     <xref ref-type="bibr" rid="CR6">6</xref>, 
     <xref ref-type="bibr" rid="CR8">8</xref>–
     <xref ref-type="bibr" rid="CR14">14</xref>]
    </td>
   </tr>
   <tr>
    <td align="left"> SCA3/MJD</td>
    <td align="left">
     <p>Portuguese, Japanese,</p>
     <p>Taiwanese,</p>
     <p>German and Brazilian</p>
    </td>
    <td align="left">ATXN3 on chromosome 14q32.12</td>
    <td align="left">Gait ataxia, pyramidal and extrapyramidal signs, nystagmus, lid retraction, decreased saccade velocity, amyotrophy fasciculations and peripheral neuropathy</td>
    <td align="left">Mild cognitive impairment, sleep disturbances and involuntary weight loss</td>
    <td align="left">Atrophy of cerebellum, brainstem, cerebellar peduncle and cranial nerves III to XII</td>
    <td align="left">
     <p>Decreased glutamate, tNAA, NAA/Cr ratio, Cho/Cr ratio, tNAA/tCr ratio and Glx/tCr ratio</p>
     <p>Increased myoinositol and tCr</p>
    </td>
    <td align="left">
     <p>Decreased GPx, 
      <sc>l</sc>-Proline and 
      <sc>l</sc>-Tryptophan
     </p>
     <p>Increased palmitoleic acid (FFA 16:1) and linolenic acid (FFA 18:3)</p>
    </td>
    <td align="left">[
     <xref ref-type="bibr" rid="CR6">6</xref>, 
     <xref ref-type="bibr" rid="CR7">7</xref>, 
     <xref ref-type="bibr" rid="CR9">9</xref>–
     <xref ref-type="bibr" rid="CR12">12</xref>, 
     <xref ref-type="bibr" rid="CR15">15</xref>–
     <xref ref-type="bibr" rid="CR17">17</xref>]
    </td>
   </tr>
   <tr>
    <td align="left"> SCA6</td>
    <td align="left">Japanese, American, German, Australian and Dutch</td>
    <td align="left">CACNA1A on chromosome 19p13.13</td>
    <td align="left">Gait ataxia, pyramidal signs, dysarthria, nystagmus, intention tremor, dystonia and dysphagia</td>
    <td align="left">Diplopia</td>
    <td align="left">Atrophy of cerebellum</td>
    <td align="left">
     <p>Decreased NAA and NAA/Cr ratio</p>
     <p>Increased myoinositol</p>
    </td>
    <td align="left">Increased glucose, taurine and lactate</td>
    <td align="left">[
     <xref ref-type="bibr" rid="CR6">6</xref>, 
     <xref ref-type="bibr" rid="CR8">8</xref>, 
     <xref ref-type="bibr" rid="CR10">10</xref>–
     <xref ref-type="bibr" rid="CR12">12</xref>]
    </td>
   </tr>
   <tr>
    <td align="left"> SCA7</td>
    <td align="left">South African, Mexican and Scandinavian</td>
    <td align="left">ATXN7 on chromosome 3p14.1</td>
    <td align="left">Gait ataxia, pyramidal signs, slow eye movements, dysmetria, hyperreflexia, dysarthria, dysphagia and ophthalmoplegia</td>
    <td align="left">Visual loss with retinopathy, cognitive impairment and psychiatric symptoms</td>
    <td align="left">Atrophy of cerebellum, brainstem, cerebral peduncle and spinal cord</td>
    <td align="left">
     <p>Decreased glutamate and tNAA</p>
     <p>Increased myoinositol and tCr</p>
    </td>
    <td align="left">Increased lipid hydroperoxides, MDA, protein carbonyls, GR, GPx and paraoxonase</td>
    <td align="left">[
     <xref ref-type="bibr" rid="CR6">6</xref>, 
     <xref ref-type="bibr" rid="CR9">9</xref>–
     <xref ref-type="bibr" rid="CR11">11</xref>, 
     <xref ref-type="bibr" rid="CR18">18</xref>, 
     <xref ref-type="bibr" rid="CR19">19</xref>]
    </td>
   </tr>
   <tr>
    <td align="left"> SCA17/HDL4</td>
    <td align="left">Japanese, German and Italian</td>
    <td align="left">TBP on chromosome 6q27</td>
    <td align="left">Gait ataxia, pyramidal and extrapyramidal signs, chorea and myoclonus</td>
    <td align="left">Cognitive impairment and psychiatric symptoms</td>
    <td align="left">Atrophy in cerebellum, brainstem and cerebrum</td>
    <td align="left">N/A</td>
    <td align="left">Decreased presynaptic dopamine transporters</td>
    <td align="left">[
     <xref ref-type="bibr" rid="CR7">7</xref>, 
     <xref ref-type="bibr" rid="CR12">12</xref>, 
     <xref ref-type="bibr" rid="CR20">20</xref>, 
     <xref ref-type="bibr" rid="CR21">21</xref>]
    </td>
   </tr>
   <tr>
    <td align="left"> EA1</td>
    <td align="left">Australian, Caucasian, American and Russian</td>
    <td align="left">KCNA1 on chromosome 12p13</td>
    <td align="left">Gait ataxia (attack last from seconds to minutes), dysarthria, seizure, myokymia, neuromyotonic and tremor</td>
    <td align="left">Vertigo, difficulty in breathing and diaphoresis</td>
    <td align="left">Normal brain</td>
    <td align="left">N/A</td>
    <td align="left">Increased GABA release</td>
    <td align="left">[
     <xref ref-type="bibr" rid="CR7">7</xref>, 
     <xref ref-type="bibr" rid="CR22">22</xref>–
     <xref ref-type="bibr" rid="CR24">24</xref>]
    </td>
   </tr>
   <tr>
    <td align="left"> EA2</td>
    <td align="left">Caucasian and Korean</td>
    <td align="left">CACNA1A on chromosome 19p13</td>
    <td align="left">Gait ataxia (attack last from minutes to hours), dysarthria, seizure, nystagmus and dystonia</td>
    <td align="left">Vertigo, nausea, headache, diplopia, tonic upward gaze and cognitive impairment</td>
    <td align="left">Atrophy of cerebellum</td>
    <td align="left">Decreased Cr and high-energy phosphate ratio</td>
    <td align="left">Increased lactate</td>
    <td align="left">[
     <xref ref-type="bibr" rid="CR7">7</xref>, 
     <xref ref-type="bibr" rid="CR11">11</xref>, 
     <xref ref-type="bibr" rid="CR22">22</xref>, 
     <xref ref-type="bibr" rid="CR23">23</xref>, 
     <xref ref-type="bibr" rid="CR25">25</xref>, 
     <xref ref-type="bibr" rid="CR26">26</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" colspan="9">Autosomal recessive</td>
   </tr>
   <tr>
    <td align="left"> FRDA</td>
    <td align="left">Caucasian, Middle East and North African</td>
    <td align="left">FXN on chromosome 9q21.11</td>
    <td align="left">Gait ataxia, eye movement abnormalities, dysarthria, dysphagia, lower extremities weakness and peripheral neuropathy</td>
    <td align="left">Skeletal deformities, hypertrophic cardiomyopathy, diabetes, deafness and optic atrophy</td>
    <td align="left">Atrophy of cerebellum and cervical spinal cord</td>
    <td align="left">
     <p>Decreased NAA/Cr ratio and Cho</p>
     <p>Increased glutamine, myoinositol and tCr</p>
    </td>
    <td align="left">N/A</td>
    <td align="left">[
     <xref ref-type="bibr" rid="CR7">7</xref>, 
     <xref ref-type="bibr" rid="CR11">11</xref>, 
     <xref ref-type="bibr" rid="CR27">27</xref>, 
     <xref ref-type="bibr" rid="CR28">28</xref>]
    </td>
   </tr>
   <tr>
    <td align="left"> AT</td>
    <td align="left">Iberian, Polish and Russian</td>
    <td align="left">ATM on chromosome 11q22.3</td>
    <td align="left">
     <p>Gait ataxia, extrapyramidal signs,</p>
     <p>oculomotor apraxia, hypotonia, areflexia and peripheral neuropathy</p>
    </td>
    <td align="left">Oculocutaneous telangiectasia, immunodeficiency, cancer susceptibility, sterility, extreme radio sensitivity, diabetes and pulmonary diseases</td>
    <td align="left">Atrophy of cerebellum and brainstem</td>
    <td align="left">
     <p>Decreased NAA, Cho, NAA/Cho ratio and Cr</p>
     <p>Increased Cho and Cho/Cr ratio</p>
    </td>
    <td align="left">
     <p>Decreased IgA, IgM, IgG2, IgE and absence of ATM protein</p>
     <p>Increased AFP</p>
    </td>
    <td align="left">[
     <xref ref-type="bibr" rid="CR1">1</xref>, 
     <xref ref-type="bibr" rid="CR7">7</xref>, 
     <xref ref-type="bibr" rid="CR11">11</xref>, 
     <xref ref-type="bibr" rid="CR29">29</xref>–
     <xref ref-type="bibr" rid="CR31">31</xref>]
    </td>
   </tr>
   <tr>
    <td align="left"> AOA1</td>
    <td align="left">Japanese and Portuguese</td>
    <td align="left">APTX on chromosome 9p21.1</td>
    <td align="left">Gait ataxia, extrapyramidal signs, oculomotor apraxia, areflexia, dysarthria, choreoathetosis, oculomotor apraxia and peripheral neuropathy</td>
    <td align="left">Cognitive impairment and skeletal deformities</td>
    <td align="left">Atrophy of cerebellum</td>
    <td align="left">N/A</td>
    <td align="left">
     <p>Decreased albumin level</p>
     <p>Increased creatine kinase and total cholesterol</p>
    </td>
    <td align="left">[
     <xref ref-type="bibr" rid="CR7">7</xref>, 
     <xref ref-type="bibr" rid="CR32">32</xref>, 
     <xref ref-type="bibr" rid="CR33">33</xref>]
    </td>
   </tr>
   <tr>
    <td align="left"> AOA2</td>
    <td align="left">Eastern French</td>
    <td align="left">SETX on chromosome 9p34.13</td>
    <td align="left">Gait ataxia, pyramidal and extrapyramidal signs, oculomotor apraxia, chorea, upper motor neuron signs, head tremor, strabismus and peripheral neuropathy</td>
    <td align="left">Mild cognitive impairment</td>
    <td align="left">Atrophy of cerebellum</td>
    <td align="left">
     <p>Decreased glutamate, NAA and NAA/Cho ratio</p>
     <p>Increased myoinositol</p>
    </td>
    <td align="left">Increased creatinine kinase, total cholesterol, AFP, IgG and IgA</td>
    <td align="left">[
     <xref ref-type="bibr" rid="CR7">7</xref>, 
     <xref ref-type="bibr" rid="CR11">11</xref>, 
     <xref ref-type="bibr" rid="CR32">32</xref>, 
     <xref ref-type="bibr" rid="CR34">34</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" colspan="9">X-linked</td>
   </tr>
   <tr>
    <td align="left"> FXTAS</td>
    <td align="left">Caucasian</td>
    <td align="left">FMR1 on X chromosome</td>
    <td align="left">Gait ataxia, intention tremor, eye movement abnormalities and peripheral neuropathy</td>
    <td align="left">Cognitive impairment, psychiatric symptoms, hearing loss and dysautonomia</td>
    <td align="left">Atrophy of cerebellum and cerebrum</td>
    <td align="left">Decreased NAA</td>
    <td align="left">N/A</td>
    <td align="left">[
     <xref ref-type="bibr" rid="CR35">35</xref>–
     <xref ref-type="bibr" rid="CR37">37</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>AFP</italic> alpha fetoprotein, 
   <italic>AOA</italic> ataxia oculomotor apraxia, 
   <italic>AT</italic> ataxia-telangiectasia, 
   <italic>Cho</italic> choline compounds, 
   <italic>Cr</italic> creatine, 
   <italic>EA</italic> episodic ataxia, 
   <italic>FRDA</italic> Friedreich’s ataxia, 
   <italic>FXTAS</italic> fragile X tremor-ataxia syndrome, 
   <italic>GABA</italic> γ-aminobutyric acid, 
   <italic>Glx</italic> glutamate + glutamine, 
   <italic>GST</italic> glutathione S-transferase, 
   <italic>GPx</italic> glutathione peroxidase, 
   <italic>GR</italic> glutathione reductase, 
   <italic>GSH</italic> glutathione, 
   <italic>HDL4</italic> Huntington disease-like 4, 
   <italic>Ig</italic> immunoglobulin, 
   <italic>MDA</italic> malondialdehyde, 
   <italic>MJD</italic> Machado-Joseph disease, 
   <italic>N/A</italic> not applicable, 
   <italic>NAA N</italic>-acetylaspartate, 
   <italic>NAAG N</italic>-acetylaspartatylglutamate, 
   <italic>PCr</italic> phosphocreatine, 
   <italic>SOD</italic> superoxide distmutase, 
   <italic>SCA</italic> spinocerebellar ataxia, 
   <italic>tCr</italic> total creatine (Cr + PCr), 
   <italic>tNAA</italic> total NAA (NAA + NAAG)
  </p>
 </table-wrap-foot>
</table-wrap>
